572 related articles for article (PubMed ID: 9001254)
1. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C.
Sartorelli V; Huang J; Hamamori Y; Kedes L
Mol Cell Biol; 1997 Feb; 17(2):1010-26. PubMed ID: 9001254
[TBL] [Abstract][Full Text] [Related]
2. The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation.
Chen SL; Dowhan DH; Hosking BM; Muscat GE
Genes Dev; 2000 May; 14(10):1209-28. PubMed ID: 10817756
[TBL] [Abstract][Full Text] [Related]
3. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation.
Eckner R; Yao TP; Oldread E; Livingston DM
Genes Dev; 1996 Oct; 10(19):2478-90. PubMed ID: 8843199
[TBL] [Abstract][Full Text] [Related]
4. The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, Twist.
Hamamori Y; Wu HY; Sartorelli V; Kedes L
Mol Cell Biol; 1997 Nov; 17(11):6563-73. PubMed ID: 9343420
[TBL] [Abstract][Full Text] [Related]
5. Multiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2.
Black BL; Molkentin JD; Olson EN
Mol Cell Biol; 1998 Jan; 18(1):69-77. PubMed ID: 9418854
[TBL] [Abstract][Full Text] [Related]
6. Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5.
Roth JF; Shikama N; Henzen C; Desbaillets I; Lutz W; Marino S; Wittwer J; Schorle H; Gassmann M; Eckner R
EMBO J; 2003 Oct; 22(19):5186-96. PubMed ID: 14517256
[TBL] [Abstract][Full Text] [Related]
7. The human T cell leukemia/lymphotropic virus type 1 Tax protein represses MyoD-dependent transcription by inhibiting MyoD-binding to the KIX domain of p300. A potential mechanism for Tax-mediated repression of the transcriptional activity of basic helix-loop-helix factors.
Riou P; Bex F; Gazzolo L
J Biol Chem; 2000 Apr; 275(14):10551-60. PubMed ID: 10744749
[TBL] [Abstract][Full Text] [Related]
8. Exogenous expression of a dominant negative RORalpha1 vector in muscle cells impairs differentiation: RORalpha1 directly interacts with p300 and myoD.
Lau P; Bailey P; Dowhan DH; Muscat GE
Nucleic Acids Res; 1999 Jan; 27(2):411-20. PubMed ID: 9862959
[TBL] [Abstract][Full Text] [Related]
9. Interaction between acetylated MyoD and the bromodomain of CBP and/or p300.
Polesskaya A; Naguibneva I; Duquet A; Bengal E; Robin P; Harel-Bellan A
Mol Cell Biol; 2001 Aug; 21(16):5312-20. PubMed ID: 11463815
[TBL] [Abstract][Full Text] [Related]
10. Sharp-1/DEC2 inhibits skeletal muscle differentiation through repression of myogenic transcription factors.
Azmi S; Ozog A; Taneja R
J Biol Chem; 2004 Dec; 279(50):52643-52. PubMed ID: 15448136
[TBL] [Abstract][Full Text] [Related]
11. The orphan nuclear receptor, COUP-TF II, inhibits myogenesis by post-transcriptional regulation of MyoD function: COUP-TF II directly interacts with p300 and myoD.
Bailey P; Sartorelli V; Hamamori Y; Muscat GE
Nucleic Acids Res; 1998 Dec; 26(23):5501-10. PubMed ID: 9826778
[TBL] [Abstract][Full Text] [Related]
12. pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation.
Novitch BG; Spicer DB; Kim PS; Cheung WL; Lassar AB
Curr Biol; 1999 May; 9(9):449-59. PubMed ID: 10322110
[TBL] [Abstract][Full Text] [Related]
13. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation.
Puri PL; Sartorelli V; Yang XJ; Hamamori Y; Ogryzko VV; Howard BH; Kedes L; Wang JY; Graessmann A; Nakatani Y; Levrero M
Mol Cell; 1997 Dec; 1(1):35-45. PubMed ID: 9659901
[TBL] [Abstract][Full Text] [Related]
14. A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program.
Mal A; Sturniolo M; Schiltz RL; Ghosh MK; Harter ML
EMBO J; 2001 Apr; 20(7):1739-53. PubMed ID: 11285237
[TBL] [Abstract][Full Text] [Related]
15. A novel E1A domain mediates skeletal-muscle-specific enhancer repression independently of pRB and p300 binding.
Sandmöller A; Meents H; Arnold HH
Mol Cell Biol; 1996 Oct; 16(10):5846-56. PubMed ID: 8816499
[TBL] [Abstract][Full Text] [Related]
16. mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo.
Dodou E; Xu SM; Black BL
Mech Dev; 2003 Sep; 120(9):1021-32. PubMed ID: 14550531
[TBL] [Abstract][Full Text] [Related]
17. Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation.
Ma K; Chan JK; Zhu G; Wu Z
Mol Cell Biol; 2005 May; 25(9):3575-82. PubMed ID: 15831463
[TBL] [Abstract][Full Text] [Related]
18. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins.
Molkentin JD; Black BL; Martin JF; Olson EN
Cell; 1995 Dec; 83(7):1125-36. PubMed ID: 8548800
[TBL] [Abstract][Full Text] [Related]
19. Dermo-1, a multifunctional basic helix-loop-helix protein, represses MyoD transactivation via the HLH domain, MEF2 interaction, and chromatin deacetylation.
Gong XQ; Li L
J Biol Chem; 2002 Apr; 277(14):12310-7. PubMed ID: 11809751
[TBL] [Abstract][Full Text] [Related]
20. Activation of the myogenic lineage by MEF2A, a factor that induces and cooperates with MyoD.
Kaushal S; Schneider JW; Nadal-Ginard B; Mahdavi V
Science; 1994 Nov; 266(5188):1236-40. PubMed ID: 7973707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
